Numerous studies have shown that severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) can infect host cells through binding to angiotensin I converting enzyme 2 (ACE2) …

Since its initial outbreak in December 2019 in Wuhan, China [1], COVID-19 has quickly and
firmly established itself as one of the most devastating global pandemics in history. Not only …

ACE2 has emerged as a double agent in the COVID-19 ordeal, as it is both physiologically
protective and virally conducive. The identification of ACE2 in as many as 72 tissues …

abstract In addition to the respiratory system, severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) strikes other systems, including the digestive, circulatory, urogenital, and …

A role of angiotensin-converting enzyme 2 (ACE2) in the coronavirus disease 2019
pandemic has been suggested, because it is the molecular receptor for severe acute …

The new Severe acute respiratory syndrome coronavirus 2 (SARS-CoV‑2) triggered the
pandemic of COVID-19, which is currently still ongoing. In 2021 a worldwide vaccine …

Aims Acute respiratory distress syndrome (ARDS), one of the serious form of acute lung
injury (ALI), is the primary cause of death in patients with ALI. Sini decoction (SND) is a …

The rapidly evolving pandemic of severe acute respiratory syndrome coronavirus (SARS-
CoV-2) infection worldwide cost many lives. The angiotensin converting enzyme-2 (ACE-2) …

Background Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) uses full-
length angiotensin converting enzyme 2 (ACE2) as a main receptor to enter target cells. The …

Severe acute respiratory syndrome-coronavirus-2 (COVID-19) virus uses Angiotensin-
Converting Enzyme 2 (ACE2) as a gateway for their entry into the human body. The ACE2 …